文献速递主动脉疾病

B型主动脉夹层腔内修复中期结果:器械特异性对比分析

Mid-Term Results of Endovascular Repair for Type B Aortic Dissection: A Device-Specific Comparative Analysis.
PubMed 文献 · Ann Vasc Surg · 2025-06-20

本研究回顾性比较了Conformable TAG(CTAG)与Valiant Captivia支架在B型主动脉夹层TEVAR中的疗效,纳入617例患者(CTAG组372例,Captivia组245例)。两组中期再入院率和主动脉相关死亡率相当,CTAG组术中I型内漏更少、住院期并发症(尤其卒中)更少,且支架段真腔扩张率更高。

要点

  • CTAG组术中I型内漏少于Captivia组(P=0.01)。
  • Captivia组住院期并发症(尤其卒中)更常见(P=0.033)。
  • CTAG组支架段真腔扩张率高于Captivia组(P<0.001)。

核心结论

  • CTAG与Captivia在TBAD患者中提供相当且良好的中期生存率和免于再入院率。
  • CTAG在TEVAR术中表现更优,减少术中I型内漏并避免住院期并发症。
  • CTAG在扩张主动脉真腔方面获得更好的主动脉重塑效果。

研究设计与样本

  • 回顾性收集并分析2016至2022年中国三级中心接受CTAG或Captivia支架治疗的TBAD患者数据。
  • 共纳入617例患者,其中CTAG组372例,Captivia组245例。
  • 比较两组术中特征、住院期短期结局、随访中期结局及主动脉重塑。

主要发现

  • CTAG组支架直径大于Captivia组(P<0.001),oversize ratio高于Captivia组(P<0.001)。
  • CTAG组术中I型内漏病例少于Captivia组(P=0.01)。
  • Captivia组住院期并发症(尤其卒中)比CTAG组更常见(P=0.033)。
  • 两组中期再入院率和主动脉相关死亡率相当。
  • CTAG组支架段主动脉真腔扩张率高于Captivia组(P<0.001)。

临床怎么用

  • 对于TBAD的TEVAR,CTAG与Captivia均可考虑,两者中期生存率和免于再入院率相当。
  • CTAG可能减少术中I型内漏和住院期并发症,并促进支架段真腔扩张。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to compare the efficacy of the Conformable TAG Thoracic Endoprosthesis (CTAG) and the Valiant Captivia System Stent Graft in thoracic endovascular aortic repair (TEVAR) for type B aortic dissection (TBAD). METHODS: TBAD patients treated from 2016 to 2022 at a Chinese tertiary center with a CTAG or Captivia stent graft were eligible for inclusion, and their data were retrospectively collected and analyzed. Intraoperative characteristics, short-term outcomes during hospitalization, mid-term outcomes during follow-up, and aortic remodeling were analyzed and compared between 2 groups. RESULTS: In total, the study included 617 patients (372 CTAG and 245 Captivia). The baseline characteristics of both groups were comparable. Procedural details showed that the CTAG group had larger stent diameter (P < 0.001) and higher oversize ratio (P < 0.001) than the Captivia group and led to less intraoperative type I endoleak cases (P = 0.01). Complications during hospitalization, especially stroke, occurred more commonly in the Captivia group (P = 0.033). Mid-term outcomes, including readmission rate and aortic-related mortality, were comparable between the 2 groups. And CTAG performed better in aortic remodeling with higher expansion rate of true lumen than Captivia in the stented segment of aorta (P < 0.001). CONCLUSION: Both CTAG and Captivia offered comparable and favorable mid-term survival rates and freedom from readmission in patients with TBAD. CTAG performed better during TEVAR operations and in short-term outcomes, including reducing intraoperative type I endoleak and avoiding complications during hospitalization. In addition, CTAG achieved an improved aortic remodeling effect in expanding the true lumen of aorta.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lu S, Kan Y, Han J, et al. Mid-Term Results of Endovascular Repair for Type B Aortic Dissection: A Device-Specific Comparative Analysis. Ann Vasc Surg. 2025. PMID: 40545191. doi:10.1016/j.avsg.2025.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。